The HGF/c-MET (mesenchymal–epithelial transition factor) pathway is emerging as a key area of focus in understanding and potentially disrupting the intricate cellular interaction that results in pancreatic cancer’s aggressiveness and resistance to treatment. This evidence concerns the gene HGF and familial pancreatic carcinoma.